UNSPSC 51162719: Guaiacol phenylacetate

This classification denotes a topical anti-infective agent and expectorant with the molecular formula C15H14O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LLO759386W, chemically known as acetic acid, phenyl-, o-methoxyphenyl ester, but more generally known as guaiacol phenylacetate, which bears US NIH Compound Identifier 61331. European Medicines Agency schedules guaiacol phenylacetate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14027MIG.

Most nations, for tariff purposes, schedule guaiacol phenylacetate under HS 29095000. SMILES: COC1CCCCC1OC(=O)CC2CCCCC2.

UNSPSC 51162719 Guaiacol phenylacetate, a Commodity code, does not align with the recent state and local contract opportunities tagged under it. The source shows no relevant activity for guaiacol phenylacetate specifically. The two recent opportunities posted under this code are for naloxone and safe drug deactivation systems (Seminole County, Florida IFB) and generic multi-source pharmaceuticals and OTC products through a multistate cooperative vehicle (Minnesota Multistate Cooperative Purchasing Alliance RFP), neither of which involves the chemical compound named in the code. The mismatch suggests either a tagging error in the source data or that guaiacol phenylacetate is not currently being solicited by state and local governments through visible procurement channels.

State and local procurement activity under this code is not currently evident in recent published solicitations. Until guaiacol phenylacetate opportunities appear in active state and local RFPs, RFQs, or ITBs, the code presents no actionable market signal for business development.